Navigating Rapid Sea Changes in First- and Later-Line Treatment of EGFR-Mutated NSCLC A Practical Framework for Optimal Biomarker Testing, Treatment Selection and Sequencing, and Adverse Event Management in Advanced NSCLC Exhibiting EGFR Exon 19 Deletions, L858R Substitutions, or Exon 20 Insertion Mutations.
- Provider:PVI, PeerView Institute for Medical Education
- Activity Link: https://www.peerview.com/EQU
- Start Date: 2024-09-07 05:00:00
- End Date: 2024-09-07 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Janssen (Any division) - Amount: 69688.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest